Autism spectrum disorder can
present itself in many ways
Do you notice irritable behaviours in your child?
Consider the Penguin study enrolling children ages 5-17
The Penguin study, which is a paediatric autism spectrum disorder (ASD) clinical study, is currently enrolling children ages 5 to 17. The purpose of the study is to evaluate an investigational drug to determine if it may treat irritability and other behaviours in children and adolescents with ASD.
To be considered for the study, patients must:
Other criteria will apply.Learn More About The Study
Do you know a young family member or loved one who is diagnosed with autism spectrum disorder? They may be eligible to participate in the Penguin study. Consider sharing information with their parents or guardians about how they can learn more.